NORDIC HEALTHY LIVING AS

Operating

K2 Vitamin - Bestselger i Norge! 50% rabatt

K2 vitamin: Opprettholder normal benbygning, hjertefunksjon og støtter god muskelfunksjon. Kjøp nå og få 90 dagers forbruk for kun 246*, ingen binding

Utvikling og salg av helse- og velværeprodukter, samt relaterte tjenester. Deltakelse i andre virksomheter.

Utvikling og salg av helse- og velværeprodukter, samt relaterte tjenester. Investering i andre virksomheter.

Organization

CEO: KS
Kristian Surén1985
Chairman of the board: KC
Knut Christian Espeseth1965
Years since formation: 21 years; since Aug 4, 2005
Type: Limited company
VAT registered: Yes
Number of employees: 8

Ownership

Number of shares and share classes: 2,241,918; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2025: 36,148,880; NOK
Annual total result 2025: -13,224,706; NOK
Total equity 2025: 36,208,376; NOK

Last update: Jul 21, 2026

Management

Management / administration

Name	Role	Shares
KS Kristian Surén 1985	Managing Director/CEO	-

Board

Name	Role	Shares
KC Knut Christian Espeseth 1965	Chairman	1.23 % indirectly
KØ Kim Øien 1968 Resigned	Board Member	23.57 % indirectly

Others

Name	Role	Shares
F FORVIS MAZARS AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
FM Frode Marc Bohan 1968	-	35.45 % indirectly
KØ Kim Øien 1968	Board Member	23.57 % indirectly
ST Sjur Thorsheim 1958	-	1.6 % indirectly
HN Henning Normann Fjøs 1965	-	1.44 % indirectly
KC Knut Christian Espeseth 1965	Chairman	1.23 % indirectly

Last update: May 10, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
I IMMUNOPHARMA AS	Ordinary shares	2,241,918	100 %

Shares owned by the NORDIC HEALTHY LIVING AS

Name	Share class	Total number of shares	Share
I IMMUNOPHARMA AS	NO0010735335	2,673,697	1.93 %

Last update: Jun 2, 2025

Group structure

IMMUNOPHARMA AS
Total operating income 2025: NOK 18,004,610
Operating profit 2025: NOK -20,461,195
Employees: 15

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	36,148,880	25,445,079	28,241,014	32,406,007	35,001,102
Annual Total Result	-13,224,706	-243,285	4,050,237	163,599	31,597,979
Total assets	78,173,694	38,123,750	40,314,894	71,307,925	119,350,604
Total liabilities	41,965,318	7,008,988	10,181,495	44,212,759	36,330,324
Total equity	36,208,376	31,114,761	30,133,398	27,095,165	83,020,280

P&L

Year	2025	2024	2023	2022	2021
Total operating income	36,148,880	25,445,079	28,241,014	32,406,007	35,001,102
Total operating costs	54,585,204	26,392,759	24,015,805	24,994,484	32,806,405
Operating result	-18,436,324	-947,680	4,225,209	7,411,522	2,194,698
Financial income/costs	77,022	323,460	601,537	-5,803,897	29,722,678
Profit before tax	-18,359,302	-624,220	4,826,746	1,607,626	31,917,376
Total tax & extraordinary income/cost	-5,134,596	-380,935	776,509	1,444,027	319,397
Annual Total Result	-13,224,706	-243,285	4,050,237	163,599	31,597,979

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	29,968,978	25,282,689	26,206,618	44,112,916	31,822,887
Total current assets	48,204,716	12,841,060	14,108,276	27,195,009	87,527,716
Total assets	78,173,694	38,123,750	40,314,894	71,307,925	119,350,604
Short term debt	41,965,318	7,008,988	10,178,084	44,212,759	36,302,878
Long term debt	0	0	3,411	0	27,446
Total liabilities	41,965,318	7,008,988	10,181,495	44,212,759	36,330,324
Contributed capital	20,560,239	2,241,918	2,241,918	2,241,918	2,241,918
Retained earnings	15,648,137	28,872,843	27,891,480	24,853,247	80,778,362
Total equity	36,208,376	31,114,761	30,133,398	27,095,165	83,020,280
Total equity and liabilities	78,173,694	38,123,750	40,314,894	71,307,925	119,350,604

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

NORDIC HEALTHY LIVING AS988 462 624